Clinical use of amino acids as dietary supplement: pros and cons
Tóm tắt
Nitrogen supply is pivotal for the maintenance of life. Amino acids can be utilized to synthesize both glucose and lipids. The opposite, i.e., production of amino acids from either one of them, is not possible in the absence of other amino acids as donors of nitrogen. The quality of amino acid content in protein has been re-evaluated recently, and the relevance of essential amino acids has been repeatedly underlined. Essential amino acid requirements in different mammals are not identical, and ratios among them should be taken into account when projecting an efficient formulation. Recent research has demonstrated that genes respond to different qualities and quantities of nutritional supply, and increased provision of essential amino acids increases lifespan in animal experiments through mitochondriogenesis and maintenance of elevated rates of synthesis of anti-oxidant molecules. Moreover, genetic expression of key controllers of synthesis, like mTOR, may be particularly important for understanding skeletal muscle maintenance. Losses of muscle mass and impaired immune function are related to reduced protein supply, and there is increasing evidence that regular essential amino acid intake as part of an oral diet is effective in reversing muscle catabolism, promoting muscle anabolism, and restoring immunological function. Therefore, the use of amino acids as supplements to diet would be expanding in the near future. Is this safe? Few data are available on amino acid toxicity, and only one essential amino acid may be considered to have clinically relevant toxicity: methionine, because it is transformed into a toxic intermediate, homocysteine, when cysteine synthesis is required by metabolic needs. Matching of stoichiometric ratios between methionine and cysteine may solve the problem of supplying sufficient amounts of sulfur to the body. Arginine and glutamine are two non-essential amino acids than can become “conditionally essential” because of elevated needs during pathological conditions, and metabolism may not be able to maintain their concentrations at sufficient levels to match metabolic requirements. Chronic exogenous arginine supplementation has not proven to exert positive clinical effects in different trials, and sequential articulation of the knowledge of introduction of arginine-driven transcriptional, translational, and epigenetic adaptations may give us a key for interpreting those puzzling results.
Tài liệu tham khảo
Schrödinger E. What is life? Cambridge: Cambridge University Press; 1944.
Jortner J. Conditions for the emergence of life on the early Earth: summary and reflections. Phil Trans Biol Sci. 2006;361:1877–91.
Bar-Nun A, Bar-Nun N, Bauer SH, Sagan C. Shock synthesis of amino acids in simulated primitive environments. Science. 1970;168:470–2.
Halac Jr E. Studies of protein reserves. The relation between protein intake and resistance to protein deprivation. Am J Clin Nutr. 1962;11:574–6.
Forbes EB, Voris L, Bratzler JW, Wainio W. The utilization of energy-producing nutrients and protein as affected by the plane of protein intake. J Nutr. 1938;15:285.
Timmerman K, Volpi E. Amino acid metabolism and regulatory effects in aging. Curr Opin Clin Nutr Metab Care. 2008;11:45–9.
Layman DK. Dietary Guidelines should reflect new understandings about adult protein needs. Nutr Metab. 2009;6:12. doi:10.1186/1743-7075-6-12.
Volpi E, Kobayashi H, Sheffield-Moore M, Mittendorfer B, Wolfe RR. Essential amino acids are primarily responsible for the amino acid stimulation of muscle protein anabolism in healthy elderly adults. Am J Clin Nutr. 2003;78:250–8.
von Haehling S, Morley JE, Anker SD. An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle. 2010;1:129–33.
Steinbock HL, Tarver H. Plasma protein.V. The effect of the protein content of the diet on turnover. J Biol Chem. 1954;209:127–32.
Drummond MJ, Glynn EL, Fry CS, Timmerman KL, Volpi E, Rasmussen B. An increase in essential amino acid availability upregulates amino acid transporter expression in human skeletal muscle. Am J Physiol Endocrinol Metab. 2010;298:E1011–8.
Pasini E, Flati V, Paiardi S, Rizzoni D, Porteri E, Aquilani R, et al. Intracellular molecular effects of insulin resistance in patients with metabolic syndrome. Cardiovasc Diabetol. 2010;9:46.
D'Antona G, Ragni M, Cardile A, Tedesco L, Dossena M, Bruttini F, et al. Branched-chain amino acid supplementation promotes survival and supports cardiac and skeletal muscle mitochondrial biogenesis in middle-aged mice. Cell Metabol. 2010;12:362–72.
Corsetti G, Stacchiotti A, D' Antona G, Nisoli E, Dioguardi FS, Rezzani R. Supplementation with essential amino acids in middle age maintains the health of rat kidney. Int J Immunopathol Pharmacol. 2010;23:523–33.
Cuthbertson D, Smith K, Babraj J, Leese G, Waddell T, Atherton P, et al. Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle. FASEB J. 2005;19:422–4. express article. 10.1096/fj.04-2640fje.
Ferrando AA, Paddon-Jones D, Hays NP, Kortebein P, Ronsen O, Williams RH, et al. EAA supplementation to increase nitrogen intake improves muscle function during bed rest in the elderly. Clin Nutr. 2010;29:18–23.
Dal Negro RW, Aquilani R, Bertacco S, Boschi F, Micheletto C, Tognella S. Comprehensive effects of supplemented essential amino acids in patients with severe COPD and sarcopenia. Monaldi Arch Chest Dis. 2010;73:25–33.
Holt Jr LE. Some problems in dietary amino acid requirements. Am J Clin Nutr. 1968;21:367–75.
Xi P, Jiang Z, Zheng C, Lin Y, Wu G. Regulation of protein metabolism by glutamine: implications for nutrition and health. Front Biosci. 2011;16:578–97.
Groody WW, Argyle C, Kern RM. Dizikes, Spector EB, Strickland AD, Klein D, Cedrebaum SD. Differential expression of the two human arginase genes in hyperargininemia. Enzymatic, pathologic and molecular analysis. J Clin Invest. 1989;83:602–9.
Dioguardi FS. To give or not to give? Lessons from arginine paradox. J Nutrigen Nutrigenom. 2011. doi:10.1159/000327777.
Allison JB. Optimal nutrition correlated with nitrogen retention. Am J Clin Nutr. 1956;4:662–72.
Young VR, Bier DM. Amino acid requirements in the adult human: how well do we know them? J Nutr. 1987;117:1484–7.
Krebs M, Krssak M, Bernroider E, et al. Mechanism of amino acid–induced skeletal muscle insulin resistance in humans. Diabetes. 2002;51:599–605.
Dioguardi FS. The alanine-arginine connection: a key piece in the puzzle of protein renal toxicity, low-protein diets, and the risk of malnutrition in patients with chronic kidney disease. Nutr Ther & Metab. 2009.27, 1, pp.
Dioguardi FS. Wasting and the substrate-to-energy controlled pathway: a role for insulin resistance and amino acids. Am J Cardiol. 2004;93:6A–12A.
De Castro Barbosa T, Lourenço Poyares L, Fabres Machado U, Nunes MT. Chronic oral administration of arginine induces GH gene expression and insulin resistance. Life Sci. 2006;79:1444–9.
Bolasco P, Caria S, Cupisti A, Secci R, Dioguardi FS. A novel amino acids oral supplementation in hemodialysis patients: a pilot study. Ren Fail. 2011;33:1–5.
Solerte SB, Gazzaruso C, Bonacasa R, Rondanelli M, Zamboni M, Basso C, et al. Nutritional supplements with oral amino acid mixtures increases whole-body lean mass and insulin sensitivity in elderly subjects with sarcopenia. Am J Cardiol. 2008;101:69E–77E.
Solerte SB, Fioravanti M, Locatelli E, Bonacasa R, Zamboni M, Basso C, et al. Improvement of blood glucose control and insulin sensitivity during a long-term (60 weeks) randomized study with amino acid dietary supplements in elderly subjects with type 2 diabetes mellitus. Am J Cardiol. 2008;101:82E–8E.
Laviano A, Aghilone F, Colagiovanni D, Fiandra F, Giambarresi R, Tordiglione P, et al. Metabolic and clinical effects of the supplementation of a functional mixture of amino acids in critically ill patients: a pilot study. Neurocritical Care. 2011;14:44–9. doi:10.1007/s12028-010-9461-z.
Aquilani R, Zuccarelli GC, Dioguardi FS, Baiardi P, Frustaglia A, Rutili C, et al. Effects of oral amino acid supplementation on long-term-care-acquired infections in elderly patients. Arch Gerontol Geriatr. 2010. doi:10.1016/j.archger.2010.09.005.
Famakin B, Weiss P, Hertzberg V, McClellan W, Presley R, Krompf K, et al. Hypoalbuminemia predicts acute stroke mortality: Paul Coverdell Georgia Stroke Registry. J Stroke Cerebrovasc Dis. 2010;19:17–22.
Jn H, Shao A. Expanded approach to tolerable upper intake guidelines for nutrients and bioactive substances. J Nutr. 2008;38:1992S–5S.
Renwick AG. Establishing the upper end of the range of adequate and safe intakes for amino acids: a toxicologist's viewpoint. J Nutr. 2004;134:1617S–24S.
Benevenga NJ, Steele RD. Adverse effects of excessive consumption of amino acids. Annu Rev Nutr. 1984;4:157–81.
Shao A, Hathcock JN. Risk assessment for the amino acids taurine, l-glutamine and l-arginine. Regul Toxicol Pharmacol. 2008;50:376–99.
Muramatsu K, Odagiri H, Morishita S, Takeuchi H. Effect of excess levels of individual amino acids on growth of rats fed casein diets. J Nutr. 1971;101:1117–26.
Li H, Lewis A, Brodsky S, Rieger R, Iden C, Goligorsky MS. Homocysteine induces 3-hydroxy-3-methyl-glutaryl coenzyme A (HMGCoA) reductase in vascular endothelial cells. A mechanism for development of atherosclerosis? Circulation. 2002;105:1037–43.
Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PW, Belanger AJ, et al. Association between plasma Homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med. 1995;332:286–91.
Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med. 1998;338:1042–50.
Morris SM. Arginine: beyond protein. Am J Clin Nutr. 2006;83:508s–12s.
Jakubowski H. Pathophysiological consequences of homocysteine excess. J Nutr. 2006;136:1741S–9S.
Di Buono M, Wykes LJ, Ball RO, Pencharz PB. Dietary cysteine reduces the methionine requirement in men. Am J Clin Nutr. 2001;74:761–6.
Schulman SP, Becker LC, Kass DA, Champion HC, Terrin ML, Forman S, et al. L-Arginine therapy in acute myocardial infarction. The vascular interaction with age in myocardial infarction (VINTAGE MI) randomized trial. JAMA. 2006;295:58–64.
Kurz S, Harrison DG. Insulin and the arginine paradox. J Clin Invest. 1997;99:369–70.
Luiking YC, Poeze M, Dejong CH, Ramsay G, Deutz NE. Sepsis: an arginine deficiency state? Crit Care Med. 2004;32:2135–45.
Bracco D. Glutamine: a double edged sword in the intensive care unit? Crit Care Med. 2005;33:2692–4.
Huang Y-F, Wang Y, Watford M. Glutamine directly downregulates glutamine synthetase protein levels in mouse C2C12 skeletal muscle myotubes. J Nutr. 2007;137:1357–62.
Cetinbas F, Yelken B, Gulbas Z. Role of glutamine administration on cellular immunity after total parenteral nutrition enriched with glutamine in patients with systemic inflammatory response syndrome. J Crit Care. 2010;25:661.e1–6.
Van der Schoor SRD, Schierbecek H, Bet PM, Veremulen MMM, Lafeberer HN, van Goudoever JB, et al. Majority of dietary glutamine is utilized in first pass in preterm infants. Pediatr Res. 2010;67:194–9.
Shambaugh GE. Urea bisosynthesis I. The urea cycle and relationships to the citric acid cycle. Am J Clin Nutr. 1977;30:2083–7.
von Haehling S, Morley JE, Coats AJ, Anker SD. Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle. J Cachexia Sarcopenia Muscle. 2010;1:7–8.